Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to our new ARUK Clinical Research Fellows, Dr Malvika Gulati and Miss Jennifer Lane on their successful Fellowship applications.

Jennifer will be studying the “Epidemiology of common hand conditions”. The project will study trends in disease variation and the surgical management of the condition at a national level using routinely collected UK GP and hospital data. Two large research studies, UK Biobank and the Million Women Study, will also be used to study over 1.8 million people to consider risk factors in developing severe osteoarthritis.

Commenting on the news of her successful application Jennifer stated “I'm thrilled to be working with ARUK for this project that I hope will help us better understand why people develop hand conditions, and aid us in determining the best surgical treatments for the future."

Jennifer will be sponsored by Prof Dominic FurnissProf Daniel Prieto-Alhambra and Prof Jane Green at the Million Women Study based in the Cancer Epidemiology Unit at the Nuffield Department of Population Health.

Dr Malvika Gulati will be looking at ”The role of gender, menopause and sex hormones in painful hand osteoarthritis (OA)”. Hand OA is common, affecting 2 million people in the UK and can cause pain, swelling and deformity and has greater occurrences in women. The project aims to improve understanding of the role of gender and hormonal influences in the pathogenesis of painful hand OA, in order to predict individual outcomes and identify new treatment strategies.

On acceptance of the award Malvika stated "I am grateful for the opportunity that Arthritis Research UK has given us. Hand osteoarthritis is the most common form of arthritis in the hand, yet treatment options are limited. This funding will allow us to better understand the condition and test our hypothesis that hormones may play a role in its development.”  

Malvika will be sponsored by Prof Fiona WattProf Tonia Vincent and Prof Nigel Arden.

FUNDING BODY

New funding for arthritis research

Similar stories

Welcome to the new Kennedy Trust CEO

The Kennedy Trust has announced Dr Stephen Simpson as its new Chief Executive Officer from 1 July 2022.

Kennedy researchers awarded funding to improve the understanding of inflammatory bowel diseases

A new £1.5M grant from the Medical Research Council (MRC) to the Powrie Group at the Kennedy Institute will help define different pathotypes of inflammatory bowel diseases that could lead to better and more focused treatments for patients.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

Wellcome Trust Investigator Award for Professor Arnon

Congratulations to Professor Arnon on her successful Wellcome Trust Investigator Award entitled: “Spatiotemporal basis of adaptive immunity in the spleen.”

New research suggests targeting blood vessels could be key to controlling fibrotic disease

By studying blood vessels at single cell resolution, Professor Jagdeep Nanchahal and colleagues found that in Dupuytren’s disease, a fibrotic disorder of the hand, the vasculature is key to orchestrating the development of human fibrosis.

Defining the role of resident memory B cells in the fight against influenza

Researchers at the Kennedy Institute of Rheumatology have used 3D and live-imaging to show how resident memory B cells boost antibodies to fight influenza.